Nucleic Acid Isolation and Purification Kits Market to Reach USD 4.82 Billion by 2030

Nucleic Acid Isolation and Purification Kits Market by Type (DNA, RNA, Total Nucleic Acid, Others), Method (Column, Magnetic Beads, Reagent), Application (Diagnostics, Personalized Medicine), End User (Pharma & Biotech, CROs) - Global Forecast to 2030
The global Nucleic Acid Isolation and Purification Kits Market is projected to grow from USD 3.02 billion in 2025 to USD 4.82 billion by 2030, registering a CAGR of 9.8% during the forecast period. Sustained expansion in molecular diagnostics, increasing PCR/qPCR and NAAT testing volumes, and the broader integration of genomics into clinical and research workflows are key factors fueling market growth.

A primary growth driver is the expanding network of hospital laboratories, diagnostic chains, and high-throughput reference labs performing routine molecular diagnostics and surveillance testing. These laboratories depend heavily on reliable DNA and RNA extraction workflows to support infectious disease testing, oncology profiling, genetic screening, and public health monitoring. As a result, demand for spin-column kits, magnetic bead-based kits, and reagent-based extraction solutions remains strong and recurring.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36573704 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36573704&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

DNA Isolation Kits Led the Market by Type in 2024

By type, the market is segmented into DNA isolation kits, RNA isolation kits, total nucleic acid isolation kits, and other specialized kits. In 2024, DNA isolation kits accounted for the largest market share.

DNA extraction remains a foundational step across multiple diagnostic and research workflows. Hospitals and diagnostic centers routinely extract DNA for genetic testing, oncology diagnostics, hereditary disease screening, and confirmatory molecular assays. The high frequency of testing and consistent consumable usage contribute to stable and repeatable revenue streams for manufacturers. As personalized medicine and oncology profiling continue to expand, DNA extraction demand is expected to remain robust.

Magnetic Bead-Based Methods Dominated in 2024

By method, the market includes magnetic bead-based, column-based (silica spin columns), reagent-based, and other technologies. Magnetic bead-based methods held the dominant share in 2024, largely due to their compatibility with automation and scalability for high-throughput laboratories.

Magnetic bead systems integrate seamlessly with automated extractors and liquid handling platforms, which are widely deployed in large hospital labs and centralized reference laboratories. Their ability to deliver consistent yields, reduce manual intervention, and support rapid turnaround times makes them particularly suitable for high-volume PCR/qPCR and NAAT workflows. As laboratory automation continues to expand, magnetic bead-based extraction is expected to maintain a competitive advantage.

Asia Pacific to Record the Fastest Growth Through 2030

Regionally, Asia Pacific is projected to grow at the fastest rate between 2025 and 2030. This growth is driven by the rapid expansion of molecular diagnostics infrastructure across hospitals, diagnostic chains, and public health laboratories.

Countries across the region are strengthening PCR and NAAT capacity while scaling disease surveillance programs, resulting in sustained and repeatable extraction kit demand. In parallel, increased adoption of next-generation sequencing (NGS) in clinical research and genomic profiling is driving the need for high-quality DNA and RNA preparation workflows. Expanding healthcare investments and laboratory modernization initiatives further support regional growth momentum.

Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=36573704 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=36573704&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Competitive Landscape

Key companies operating in the nucleic acid isolation and purification kits market include Thermo Fisher Scientific, QIAGEN, F. Hoffmann-La Roche, Agilent Technologies, Inc., and Takara Bio Inc., along with several other regional and global participants.

These companies are focusing on automation-ready platforms, improved reagent chemistries, and workflow-integrated solutions to strengthen their competitive positioning in both clinical diagnostics and research applications.

Market Outlook

As molecular diagnostics becomes a standard component of routine healthcare and public health surveillance, nucleic acid extraction remains a critical enabling step. Continued investments in automation, genomics, and precision medicine are expected to sustain steady growth in the nucleic acid isolation and purification kits market through 2030.

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=nucleic-acid-isolation-and-purification-kits-market-to-reach-usd-482-billion-by-2030]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-and-purification-kits-market-36573704.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.